Integer Holdings Co. (NYSE:ITGR) Shares Bought by Handelsbanken Fonder AB

Handelsbanken Fonder AB lifted its position in shares of Integer Holdings Co. (NYSE:ITGR) by 27.7% during the third quarter, Holdings Channel.com reports. The firm owned 10,137 shares of the medical equipment provider’s stock after acquiring an additional 2,200 shares during the period. Handelsbanken Fonder AB’s holdings in Integer were worth $1,318,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also made changes to their positions in ITGR. Driehaus Capital Management LLC grew its stake in shares of Integer by 62.5% during the 2nd quarter. Driehaus Capital Management LLC now owns 353,052 shares of the medical equipment provider’s stock worth $40,880,000 after purchasing an additional 135,750 shares during the period. F M Investments LLC acquired a new stake in shares of Integer during the 2nd quarter worth approximately $11,143,000. Point72 Europe London LLP acquired a new stake in shares of Integer during the 2nd quarter worth approximately $6,241,000. Congress Asset Management Co. MA grew its stake in shares of Integer by 12.5% during the 4th quarter. Congress Asset Management Co. MA now owns 421,524 shares of the medical equipment provider’s stock worth $41,765,000 after purchasing an additional 46,776 shares during the period. Finally, Earnest Partners LLC grew its stake in shares of Integer by 3.2% during the 2nd quarter. Earnest Partners LLC now owns 1,208,319 shares of the medical equipment provider’s stock worth $139,911,000 after purchasing an additional 37,340 shares during the period. Institutional investors and hedge funds own 99.29% of the company’s stock.

Insider Transactions at Integer

In related news, Director Jean M. Hobby sold 11,960 shares of the company’s stock in a transaction that occurred on Wednesday, July 31st. The stock was sold at an average price of $119.66, for a total value of $1,431,133.60. Following the transaction, the director now directly owns 2,280 shares in the company, valued at approximately $272,824.80. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders own 2.00% of the company’s stock.

Analysts Set New Price Targets

ITGR has been the topic of a number of analyst reports. Citigroup raised their price objective on shares of Integer from $124.00 to $130.00 and gave the stock a “neutral” rating in a research note on Tuesday, October 1st. Benchmark reiterated a “buy” rating and set a $130.00 target price on shares of Integer in a research report on Wednesday, October 2nd. Bank of America increased their target price on Integer from $135.00 to $145.00 and gave the company a “buy” rating in a research report on Tuesday, October 1st. Truist Financial increased their target price on Integer from $137.00 to $145.00 and gave the company a “buy” rating in a research report on Tuesday, October 1st. Finally, Oppenheimer began coverage on Integer in a research report on Tuesday, July 16th. They set an “outperform” rating and a $135.00 target price on the stock. One research analyst has rated the stock with a hold rating and six have issued a buy rating to the stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $137.29.

Integer Trading Up 0.8 %

Shares of ITGR stock opened at $129.24 on Friday. The stock’s fifty day moving average is $124.67 and its two-hundred day moving average is $119.93. The company has a debt-to-equity ratio of 0.73, a quick ratio of 1.96 and a current ratio of 3.29. The firm has a market capitalization of $4.33 billion, a P/E ratio of 42.24, a PEG ratio of 1.86 and a beta of 1.08. Integer Holdings Co. has a fifty-two week low of $69.40 and a fifty-two week high of $131.87.

Integer (NYSE:ITGR) last announced its quarterly earnings data on Thursday, July 25th. The medical equipment provider reported $1.30 earnings per share for the quarter, beating analysts’ consensus estimates of $1.24 by $0.06. Integer had a return on equity of 11.48% and a net margin of 6.31%. The company had revenue of $436.20 million for the quarter, compared to analyst estimates of $437.00 million. During the same quarter last year, the firm posted $1.14 EPS. The firm’s revenue for the quarter was up 9.0% on a year-over-year basis. Research analysts expect that Integer Holdings Co. will post 5.3 earnings per share for the current fiscal year.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.